RNA Editing – Talk Bio

Actionable Insights Powered by AI

AIRNA nets $155M series B to launch clinical test of RNA editing tech

3 weeks ago talkbio0Tagged AIR-001, Airna, RNA, RNA Editing

RNA Editing, Airna, AIR-001, RNA

Wave Life Sciences Sees Historic Stock Surge Following Breakthrough in RNA Editing Therapy

6 months ago talkbio0Tagged Clinical Trials, Hereditary Diseases, liver complications, Lung, RNA Editing, surge, Wave Life Sciences, WVE-006

Wave Life Sciences, RNA editing, genetic condition, lung and liver complications, WVE-006, biotech, stock surge, clinical trial data

Novo Nordisk and Korro Bio Collaborate on $530M RNA Editing Deal for Cardiometabolic Diseases

7 months ago talkbio0Tagged Bio, cardiometabolic diseases, genetic medicines, Korro, Nordisk, pharmaceutical partnerships, RNA Editing

Novo Nordisk, Korro Bio, RNA editing, cardiometabolic diseases, genetic medicines, pharmaceutical partnerships

Biotech Startup Airna Secures $60M to Advance RNA-Editing Therapy for Alpha-1 Antitrypsin Deficiency

9 months ago talkbio0Tagged ADAR gene, Airna, alpha 1-Antitrypsin Deficiency, Alpha-1, Antitrypsin Deficiency, Clustered Regularly Interspaced Short Palindromic Repeats, Genetic Medicine, RNA Editing, RNA therapy, startup

Airna, RNA editing, alpha-1 antitrypsin deficiency, AATD, biotech startup, genetic medicine, ADAR, CRISPR, RNA therapy